Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

A holistic approach combining medical, surgical, and psychological therapies is essential for effectively managing diabetes.

Take care of your hair as much as your face for a youthful look.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

Including androgens in hormone therapy may lower breast cancer risk.

Estrogen deficiency in postmenopausal women can cause skin and hair issues, but local estrogen therapies help improve vaginal health.

Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Chemoprevention, using drugs like finasteride and dutasteride, can help prevent prostate cancer.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

We need better ways to test and understand SARMs to make safer and more effective treatments.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Anabolic steroids and SARMs can cause serious liver damage.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

GTx-024 and Danazol affect the uterus like DHT, while GTx-007 has little impact.